IBEC Seminar: Shahid Uddin
Friday, July 5 @ 10:00 am–12:00 pm
Developability assessment of biologics and formulation of novel molecules
Shahid Uddin, PhD, MBA, Senior Director of Drug Product, Formulation & Stability within the CMC department at Immunocore, UK
It’s vital to ensure appropriate assessment of molecules at the early research phase is carried out to risk mitigate movement into the development phase. This ensures the best risk of success with minimal usage of resources and finances. This presentation will highlight the procedures for assessing developability and also showcases the challenges associated with administering low-concentration biologics.
